Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
about
Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update.Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.Migraine and risk of hemorrhagic stroke: a study based on data from general practice.Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients.Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.Risk Factors for Lobar and Non-Lobar Intracerebral Hemorrhage in Patients with Vascular Disease.Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies.Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.Paradoxical Increase in Mortality and Rupture of Intracranial Aneurysms in Microsomal Prostaglandin E2 Synthase Type 1-Deficient Mice: Attenuation by AspirinSickle Cell Disease and Stroke: Diagnosis and Management.Clinical outcome and prognostic factors of patients with angiogram-negative and non-perimesencephalic subarachnoid hemorrhage: benign prognosis like perimesencephalic SAH or same risk as aneurysmal SAH?Alcohol Consumption and Aneurysmal Subarachnoid Hemorrhage.Aspirin and intracerebral hemorrhage: Where are we now?Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk.Aspirin for the Prevention of Intracranial Aneurysm Rupture.Association of intracranial aneurysm rupture with smoking duration, intensity, and cessation.[Oral anticoagulant-associated intracerebral haemorrhage].Altered Mental Status: Current Evidence-based Recommendations for Prehospital Care.Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based studyRisk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study
P2860
Q26998381-B694C924-09DE-4CBD-A835-2840DF037D0AQ30238502-D54AF35B-BBA2-4D37-AC93-FD35565AC0EDQ30276622-29EDD9C4-19BC-4A77-9765-19445398E148Q30868786-AFD22595-5EF4-426E-87E1-1AD30BF7B08CQ33870036-75623CEE-DCBE-41E3-813E-372D7F1030F2Q34555332-D65BA9C4-41E3-422B-AAA4-3D78329BDC9AQ35833463-8DAD408A-5E02-42E7-8363-BA45A52B26D6Q36094923-9CB7E27C-60D8-4729-95C9-5EAE79CC6627Q36117689-92B24264-8E74-4360-8059-D318922945E3Q36839655-1A43346C-B355-454C-ADAD-56D630033DD5Q38732049-04AA7AFA-895D-4749-A85B-8918E1AEDDECQ40219518-48092AE7-7D21-441B-9540-8602F1EE3B80Q48331982-659C8455-7442-4CD1-8805-22042DF12EAFQ49328817-89C9D544-DBCE-42DC-B9C8-29FD269DF737Q49920953-69654702-F37D-456B-990E-8A7A18CD7185Q50130475-16CFC787-6495-46C4-B280-870B9E6A76A8Q50266292-4E02F22B-376C-4294-8DE9-ED5C2D4BA992Q54127394-119F3F2A-41C5-4AF7-8953-427154A26D50Q55250661-3B924CA4-3391-4035-AE9F-04443439C7D6Q58703004-47BAF0A1-F021-4958-89E1-579F1E7DC663Q58715507-4EB69F9C-627F-4DD8-8B17-9D345217075B
P2860
Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
@en
type
label
Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
@en
prefLabel
Antithrombotic drugs and risk of hemorrhagic stroke in the general population.
@en
P2093
P1433
P1476
Antithrombotic drugs and risk of hemorrhagic stroke in the general population
@en
P2093
Antonio González-Pérez
Charlotte Cookson
Jonathan Morton
Luis A García-Rodríguez
P304
P356
10.1212/WNL.0B013E31829E6FFA
P407
P50
P577
2013-07-10T00:00:00Z